Who is sponsoring NCT04259489?

NCT04259489 is sponsored by Beijing Chao Yang Hospital.

What drugs are being tested in NCT04259489?

Interventions in NCT04259489: Shared Care diabetes management.

What condition does NCT04259489 study?

NCT04259489 studies Type 2 Diabetes.

Is NCT04259489 still recruiting?

NCT04259489 is currently status unknown. Last updated 6 February 2020.

Last reviewed 2020-02-06 · How we verify

NCT04259489: ESCDM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of SCDM in Patients With Type 2 Diabetes

Status unknown NA Last updated 6 February 2020

What this trial tests

NA trial testing Shared Care diabetes management in Type 2 Diabetes in 210 participants. Status unknown.

Timeline

31 January 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Beijing Chao Yang Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	210
Start date	31 January 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across China

Drugs / interventions tested

Shared Care diabetes management

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

Beijing Chao Yang Hospital

Who can join

Adults 18 to 80, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomization, parallel, controlled study, which conducted to evaluate the effectiveness and related influencing factors of the Shared Care multidisciplinary diabetes care model. Patients with T2DM involved in the Shared Care model pay regularly quarterly visit to a multidisciplinary team led by physician at outpatient clinic, and receive remote and systematic management and education online after going home. After at least one year follow-up, evaluate the glycemic achieving rate (HbA1c\<7%), the diabetes self-management behavior change and the effect of online diabetes self-management support for patients of the Shared Care multidisciplinary diabetes care model.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ, Machiyama K, Woodd S, Gubijev A, et al · · 2021 · cited 25× · PMID 33769555 · DOI 10.1002/14651858.cd012675.pub3

Verify or expand the search:

Other trials of Shared Care diabetes management

Trials testing the same drug.

NCT04100278 — Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes · NA · unknown

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other Beijing Chao Yang Hospital trials

Trials by the same sponsor.

NCT07520305 — Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes · NA · not yet recruiting
NCT07490925 — Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS · NA · not yet recruiting
NCT07382986 — IMPACT COPD Cohort (China) · recruiting
NCT07323134 — The Effect of Semaglutide on the Intestinal Flora in Obesity · not yet recruiting
NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04259489 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Chao Yang Hospital
Last refreshed: 6 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04259489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing